De Matteis S, Del Coco L, De Castro F, Giudetti AM, Casadei B, Iannotta F, De Felice F, Tomassini E, Vaglio F, Naddeo M, Salamon I, Storci G, Laprovitera N, Messelodi D, Bertuccio SN, Tassoni M, Sinigaglia B, Barbato F, Ursi M, Campanini E, Maffini E, Roberto M, Pellegrini C, Dan E, Pirazzini C, Garagnani P, Ferracin M, Zinzani PL, Fanizzi FP, Bonafè M, Bonifazi F. Metabolic profile evolution in relapsed/refractory B-cell non-Hodgkin lymphoma patients treated with CD19 chimeric antigen receptor T-cell therapy and implications in clinical outcome. haematol [Internet]. 2020Sep.10 [cited 2024Dec.28];. Available from: https://haematologica.org/article/view/11875